Cvs Pharmacy #00943 Durable Medical Equipment & Medical Supplies Location: 1200 Main St, Willimantic, Connecticut 06226 Phone: (860) 456-5931 |
Robert F Dibble Medicare Supplier Location: 1120 Main St, Willimantic, Connecticut 06226 Phone: (860) 456-8889 |
Willimantic Pharmacy Durable Medical Equipment & Medical Supplies Location: 972 Main St, Willimantic, Connecticut 06226 Phone: (860) 423-9600 |
Stop & Shop Pharmacy #674 Durable Medical Equipment & Medical Supplies Location: 1391 Main St, Willimantic, Connecticut 06226 Phone: (860) 456-7240 |
Walgreens #7333 Durable Medical Equipment & Medical Supplies Location: 1475 Main St, Willimantic, Connecticut 06226 Phone: (860) 423-6304 |
Windham Eye Group Pc Eyewear Supplier (Equipment, not the service) Location: 83 Quarry St, Willimantic, Connecticut 06226 Phone: (860) 423-1619 |
News Archive
With predictions that drug-resistant ‘superbugs' could cause up to 10 million deaths a year by 2050, a new CSIRO survey has revealed a low level of community knowledge about antibiotics.
Exposure to high levels of alcohol in adolescence may shape adult behaviors, predisposing them to a higher risk of anxiety and alcohol abuse later in life, a new study found.
Experience hearing a person's voice allows us to more easily hear what they are saying. Now research by UC Riverside psychology Professor Lawrence D.
A team from the Department of Mechanical Engineering and the Biomedical Engineering Research Centre (CREB) of the Universitat Politècnica de Catalunya. BarcelonaTech (UPC) has developed an active knee-ankle orthosis to assist gait in people with incomplete spinal cord injury. The project is being carried out in collaboration with the University of A Coruña and the University of Extremadura.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
› Verified 7 days ago